Article
Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor.
Cancer chemotherapy and pharmacology - 1 Jan 2015
Koo Dong-Hoe, Ryu Min-Hee, Ryoo Baek-Yeol, Beck Mo Youl, Na Young-Soon, Shin Jae-Gook, Lee Sang Seop, Kim Eun-Young, Kang Yoon-Koo
Abstract excerpt
PURPOSE: Imatinib is a substrate of drug transporters and metabolizing enzymes, including members of the cytochrome P450 (CYP) system. Differences in imatinib pharmacokinetics among individuals might be influenced by genetic polymorphisms and be associated with variable clinical imatinib efficacy. This study sought to test how genetic polymorphisms can affect the clinical efficacy of imatinib and its blood levels...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
